News
Triplet shows ‘promising’ activity in unresectable/metastatic CRC
Panitumumab plus ipilimumab and nivolumab induced responses in more than a third of patients.
Article
Coronasomnia: Pervasive sleeplessness, self-medicating raise concerns of sleep experts
Lockdown-related stress and psychological factors may play a role, but SARS-CoV-2 may also have still-unrecognized central nervous system effects...
News
Higher intensity therapy doesn’t increase surgical risk in esophageal cancer
Neither radiation nor docetaxel added to neoadjuvant cisplatin plus 5-fluorouracil increased the risk of perioperative complications when compared...
News
Boost dose reduces recurrence in high-risk DCIS
Adding a tumor bed boost to whole breast irradiation cut the risk of local recurrence in half, regardless of fractionation.
News
Bemarituzumab FIGHTs gastric/GEJ cancers, improving survival
Bemarituzumab improved progression-free and overall survival.
News
Adding atezolizumab to chemo doesn’t worsen QOL in early TNBC
After an initial decline, quality of life measures rebounded for patients treated with atezolizumab or placebo plus chemotherapy.
News
Durable responses with anti-BCMA CAR T-cell for multiple myeloma
Seventy-two percent of patients with relapsed/refractory multiple myeloma had ongoing responses at the time of data cutoff in the CARTITUDE-1...
News
AASLD 2020: A clinical news roundup
A panel of reviewers highlighted abstracts from the digital edition of the 2020 Liver Meeting in the annual Clinical News Debrief.